Novartis2d
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G)
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...
Novartis19h
Careers at Novartis in Slovenia
At Novartis, we innovate, develop and operate on a vast scale. You can be part of it. Join our creative community of professionals and you will find opportunities to make an unprecedented impact – on ...
Novartis18h
Career Search
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.
Novartis19h
Zaposlitev v Novartisu v Sloveniji
V Novartisu spodbujamo inovativnost in razvoj ter delujemo na številnih področjih. Tudi vi lahko postanete del tega, del naše zgodbe. Pridružite se naši ustvarjalni skupnosti strokovnjakov in našli ...
Novartis18h
Nové pracovní příležitosti
Prozkoumejte pracovní příležitosti ve společnosti Novartis v seznamu níže. Pro další pozice ve společnosti Novartis Gene Therapies (dříve AveXis) navštivte GTx Hledání práce. Medical Science Liaison ...
Novartis23h
Αναζήτηση θέσεων εργασίας
Εξερευνήστε ευκαιρίες στη Novartis και στη Sandoz παρακάτω. Για επιπλέον ρόλους στη Novartis Gene Therapies (πρώην AveXis) επισκεφτείτε την Αναζήτηση ...
Novartis2d
Carrières zoeken
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search. Medical Science Liaison Manager, RLT ...
Novartis6d
Código de ética
Novartis se compromete a garantizar que nuestros asociados estén capacitados para hacer lo correcto. El 1ro de septiembre de 2020 introdujimos nuestro nuevo Código de Ética de Novartis. Código de ...